Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3SMS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,484
Award facts
- Contract value 100% obligated
- $63,484.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $63,484.43 for DUPIXENT 300 MG/2 ML pens on December 30, 2025, with a completion deadline of December 31, 2025. This firm fixed-price contract utilizes no set-aside designation and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. This specific delivery order for DUPIXENT—a biologic medication used to treat atopic dermatitis, asthma, and other allergic conditions—demonstrates the company's role in fulfilling specialized pharmaceutical needs within the Defense Health Agency's medical supply chain. The award reflects AmerisourceBergen's demonstrated capability to compete successfully for federal medical supply contracts and represents a discrete fulfillment under its expansive pharmaceutical prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26F3SMS?
SPE2DR26F3SMS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F3SMS worth?
The government has obligated $63,484 on SPE2DR26F3SMS.
Is contract SPE2DR26F3SMS an order under another contract?
Yes. SPE2DR26F3SMS is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SMS competed?
The extent of competition for SPE2DR26F3SMS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award